Search results

A revised model has been developed that can more accurately predict the actual service life of an industrial component.

A large international team has provided an understanding of how nanoscale interactions affect the thermal stability of a type of next generation organic solar cells.

ANSTO offers accelerator-based particle-induced gamma-ray emission techniques to determine total fluorine concentration in a range of solid materials and rapidly screen for the presence of PFAS (perfluoroalkyl and polyfluoroalkyl substances).

ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.

The Nobel Prizes for Physics, Chemistry and Medicine have been announced. 

ANSTO recently hosted a public Ask Us Anything event on nuclear medicine, sharing information on how we safely manufacture and distribute nuclear medicine across Australia each week to hundreds of hospitals and clinics.

ANSTO researchers have demonstrated longstanding expertise in the study of nuclear fuel and radioactive waste with two recent journal articles in a special issue of Frontiers of Chemistry.

ANSTO is pleased to welcome The Hon Dr Annabelle Bennett AO SC as the new ANSTO Board Chairperson, following the announcement from the Minister for Industry, Science and Technology. 

Australia’s best known carnivorous dinosaur Australovenator is under the microscope at ANSTO

Following your experiment at ANSTO there are certain tasks that users can complete including a user feedback survey and claiming reimbursement for travel expenses.

Neutron Capture Enhanced Particle Therapy developed at ANSTO.

We have provided answers to some the frequently asked questions about the CORIS360® imaging technology.